European research study aims to improve treatment for traumatic brain injury

ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has contributed to a complex pan-European traumatic brain injury (TBI) research study involving over 4,500 patients in 65 sites in 20 European countries.

ICON provided site management and source data verification (SDV) services to the study, which was supported by the EU and led by Professor Andrew Maas from the University Hospital Antwerp (Belgium) and Professor David Menon from the University of Cambridge (UK). ICON’s Dr Valérie Legrand, VP Project Management and a recognised expert in CNS, also provided clinical expertise as a member of the project’s Management Committee.

The Lancet Neurology Commission on TBI was launched at the European Parliament on 7th November 2017 and set out clinical and research priorities and recommendations to address the varied challenges in TBI.

The Commission on TBI identifies 12 key recommendations and policies to improve the prevention, quality of care and clinical research in TBI. It seeks to identify strategies to better characterise TBI, increase prognostic accuracy, and adopt a more precision-medicine approach to treatments. The Commission also promotes the use of new tools for clinical evidence generation and implementation, so that research outputs can be more rapidly integrated into clinical care. Moreover, it highlights the importance of international collaboration of funding agencies and researchers to provide a global response to reduce the individual and societal burden of TBI.

Source: ACNR 

Visit ACNR at Stand 4092 at the European Neuro Convention.

Visit ACNR's website here

Register for ACNR's newsletter here

ACNR reaches 4200 specialist neurology readers in the UK, including all the UK’s consultant and trainee neurologists (members of the ABN), as well as rehabilitation consultants and trainees, specialist nurses and AHPs. Our sister publication Neurodigest reaches a further 1000 community rehabilitation AHPs, offering comprehensive coverage of the field.

To see the latest development in neurorehabilitation, register for your free ticket to attend the European Neuro Convention.

If you are interested in exhibiting to thousands of neuro professionals, actively looking to purchase the latest technology, please contact Nick Woore, Event Director, to discuss exhibiting opportunities on:

Tel: 0117 929 6097

Email: Nick.Woore@prysmgroup.co.uk